About
Solutions
Pipeline
Publications
News
Careers
Contact Us
en
Open main menu
News
Loading...
CN
Track Our News on
All
Press Release
Media Coverage
All
2023-11-06
2023-11-06
2023-10-20
2023-10-18
2023-10-11
2023-09-07
2023-09-01
2023-08-10
2023-07-29
2023-07-18
2023-06-12
2023-04-05
Previous
3 / 5
Next
Previous
3 / 5
Next
MindRank Founder Zhangming Niu Named to Hurun China Under40s 2023
MindRank Nominates a Preclinical Candidate with Dual-Target Capabilities for IND-Enabling Studies, the “First-in-Class” in the DDR Area
MindRank Awarded “Future Unicorn | The Inaugural Dual 30 AI Ranking of Innovative Companies” by KPMG China
Journal of Biomolecular Structure and Dynamics | The Binding Mechanism of Failed, in Processing and Succeed Inhibitors Target SARS-CoV-2 Main Protease
Bioinformatics | An Extensive Benchmark Study on Biomedical Text Generation and Mining with ChatGPT
MindRank Announces the Commencement of Phase IIa Clinical Study of MDR-001 in China
MindRank Features in Forbes Asia 100 to Watch 2023 List
MindRank Secures Funding from the Dynamic Resilience Program for its Pan-European Collaborative Project
ICML 2023 | Rethinking Explaining Graph Neural Networks via Non-parametric Subgraph Matching
MindRank Secures Over $20 Million in A+ Round Financing, Propelling Innovative Drug Pipeline and AI Platform Commercialization
News - MindRank
MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China
Commun. Chem. (Nature) | Pharmacophoric-Constrained Heterogeneous Graph Transformer Model for Molecular Property Prediction
